In Conversation With Aquest: CBI’s Dear CEO Letter

August 10, 2020

A (very) Brief History

Since 2014, the Central Bank of Ireland (CBI) has focused on shining a spotlight on the effectiveness of Irish fund management companies. Through its consultation paper “Guidance on Fund Management Company Effectiveness” — colloquially referred to within industry as CP86, and finalized in late 2016 — the CBI introduced new governance requirements including rules on board composition, director time commitments, organizational effectiveness, prescribed managerial functions, and a number of other governance and oversight obligations. Ireland is not alone in its focus on board responsibilities and corporate governance, but the level of detail and prescription the CBI has used in assessing governance standards is unique.

CP86 was anything but a “set it and forget it” project once it was finalized in 2016. Since then, the CBI has maintained its focus on fund governance and has raised the bar with regard to substance and governance, most notably for new applicants setting up an Irish fund management company as a result of Brexit. In 2019, the CBI began a thematic review of the implementation of CP86 when it wrote to over 300 Irish management companies (ManCos) and self-managed investment companies (SMICs) asking questions of their governance structures, level of delegate oversight, detailed analysis of director time commitments, and how the organizational effectiveness of the boards was functioning. 

After this industry-wide outreach, the CBI began a series of desktop reviews of a sample of ManCos and SMICs in late 2019. This has continued into 2020, with many reviews occurring remotely due to the COVID-19 pandemic. The desktop reviews exhibited an increased level of granularity and homed in on background and qualifications of Designated Persons, requesting the appointment letters of designated persons, review of management reporting received from fund delegates, board materials, and proof of independent assessment by appointed designated persons. The desktop reviews specifically examined the role of the director with responsibility for organizational effectiveness and requested items such as organizational effectiveness reports and the required board assessment questionnaires, which the OE director is responsible for compiling. The reviews have also included interviews with a range of directors and designated persons with a goal of compiling a broad picture of the steps taken to comply with CP86 across the industry. 

What to Expect?

Now with that work completed, the industry awaits with bated breath the publication of the CBI’s findings. It is expected that the findings will come in the form of an industry wide “Dear CEO” letter. The timing of release remains unknown, but many believe it will come in September. Several questions remain, but it is widely expected that there will be changes required to existing governance requirements across a range of areas including:

  • Headcount Requirements – This will be dependent on the nature, scale, and complexity of funds
  • Organizational Effectiveness – There is a heightened expectation on report compilation
  • Director Time Commitments – The expectation is that the CBI will once more raise the bar in time to be committed to oversight responsibilities
  • Chain of Approvals – The CBI is increasingly focused on full board approvals for fund authorizations and changes to fund documentation in advance of these being submitted to the CBI for review

With all of that in mind, I recently spoke with Daniel Lawlor, Managing Director from Aquest and former Central Bank of Ireland supervisor about the forthcoming CBI CP86 Dear CEO letter.

Click here for the conversation

Brown Brothers Harriman & Co. (“BBH”) may be used as a generic term to reference the company as a whole and/or its various subsidiaries generally. This material and any products or services may be issued or provided in multiple jurisdictions by duly authorized and regulated subsidiaries.This material is for general information and reference purposes only and does not constitute legal, tax or investment advice and is not intended as an offer to sell, or a solicitation to buy securities, services or investment products. Any reference to tax matters is not intended to be used, and may not be used, for purposes of avoiding penalties under the U.S. Internal Revenue Code, or other applicable tax regimes, or for promotion, marketing or recommendation to third parties. All information has been obtained from sources believed to be reliable, but accuracy is not guaranteed, and reliance should not be placed on the information presented. This material may not be reproduced, copied or transmitted, or any of the content disclosed to third parties, without the permission of BBH. All trademarks and service marks included are the property of BBH or their respective owners.© Brown Brothers Harriman & Co. 2020. All rights reserved.

This browser is not fully supported by our public website and may not display or function as expected for this reason. Please note, the Infuse Portal and BBH client applications fully support the IE 11 browser.

Important Information for Non-U.S. Residents

You are required to read the following important information, which, in conjunction with the Terms and Conditions, governs your use of this website. Your use of this website and its contents constitute your acceptance of this information and those Terms and Conditions. If you do not agree with this information and the Terms and Conditions, you should immediately cease use of this website. The contents of this website have not been prepared for the benefit of investors outside of the United States. This website is not intended as a solicitation of the purchase or sale of any security or other financial instrument or any investment management services for any investor who resides in a jurisdiction other than the United States1. As a general matter, Brown Brothers Harriman & Co. and its subsidiaries (“BBH”) is not licensed or registered to solicit prospective investors and offer investment advisory services in jurisdictions outside of the United States. The information on this website is not intended to be distributed to, directed at or used by any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation. Persons in respect of whom such prohibitions apply must not access the website.  Under certain circumstances, BBH may provide services to investors located outside of the United States in accordance with applicable law. The conditions under which such services may be provided will be analyzed on a case-by-case basis by BBH. BBH will only accept investors from such jurisdictions or countries where it has made a determination that such an arrangement or relationship is permissible under the laws of that jurisdiction or country. The existence of this website is not intended to be a substitute for the type of analysis described above and is not intended as a solicitation of or recommendation to any prospective investor, including those located outside of the United States. Certain BBH products or services may not be available in certain jurisdictions. By choosing to access this website from any location other than the United States, you accept full responsibility for compliance with all local laws. The website contains content that has been obtained from sources that BBH believes to be reliable as of the date presented; however, BBH cannot guarantee the accuracy of such content, assure its completeness, or warrant that such information will not be changed. The content contained herein is current as of the date of issuance and is subject to change without notice. The website’s content does not constitute investment advice and should not be used as the basis for any investment decision. There is no guarantee that any investment objectives, expectations, targets described in this website or the  performance or profitability of any investment will be achieved. You understand that investing in securities and other financial instruments involves risks that may affect the value of the securities and may result in losses, including the potential loss of the principal invested, and you assume and are able to bear all such risks.  In no event shall BBH or any other affiliated party be liable for any direct, incidental, special, consequential, indirect, lost profits, loss of business or data, or punitive damages arising out of your use of this website. By clicking accept, you confirm that you accept  to the above Important Information along with Terms and Conditions.

 
1BBH sponsors UCITS Funds registered in Luxembourg, in certain jurisdictions. For information on those funds, please see bbhluxembourgfunds.com


captcha image

Type in the word seen on the picture

I am a current investor in another jurisdiction